Vaccine Safety Screening For Adventitious Agents Looms Large At Substrates Cmte.
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Vaccine and Related Biological Products Advisory Committee will examine the role of emerging technologies for detecting adventitious agents in assessing whether novel human tumor-derived cell-line substrates are suitable for vaccine production.